Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,776 | -47,762 | -31,074 | -20,539 | -7,745 |
| Depreciation Amortization | 32 | 154 | 115 | 71 | 35 |
| Other Working Capital | 2,827 | -1,241 | -908 | 1,243 | 705 |
| Other Operating Activity | 949 | 3,593 | 2,199 | 1,603 | 832 |
| Operating Cash Flow | $-15,968 | $-45,257 | $-29,668 | $-17,623 | $-6,173 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -175 | -200 | -200 | -200 | -150 |
| Investing Cash Flow | $-175 | $-200 | $-200 | $-200 | $-150 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -102 | -3 | -3 | -2 | -1 |
| Common Stock Issued | 97 | 10,487 | 10,463 | 8,344 | 1,154 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -162 |
| Financing Cash Flow | $-6 | $10,484 | $10,460 | $8,342 | $991 |
| Beginning Cash Position | 68,135 | 103,108 | 103,108 | 103,108 | 103,108 |
| End Cash Position | 51,986 | 68,135 | 83,700 | 93,627 | 97,777 |
| Net Cash Flow | $-16,149 | $-34,973 | $-19,408 | $-9,481 | $-5,331 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,968 | -45,257 | -29,668 | -17,623 | -6,173 |
| Capital Expenditure | -175 | -200 | -200 | -200 | -150 |
| Free Cash Flow | -16,143 | -45,457 | -29,868 | -17,823 | -6,323 |